These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 571341)

  • 1. Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.
    Rusterholz DB; Long JP; Flynn JR; Cannon JG; Lee T; Pease JP; Clemens JA; Wong DT; Bymaster FP
    Eur J Pharmacol; 1979 Apr; 55(1):73-82. PubMed ID: 571341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine-induced rotation in normal rats and interaction with unilateral caudate lesions.
    Jerussi TP; Glick SD
    Psychopharmacologia; 1975; 40(4):329-34. PubMed ID: 1096216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic activity of some apomorphine analogs.
    Cheng HC; Long JP; Van Orden LS; Cannon JG; O'Donnell JP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):89-106. PubMed ID: 968179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.
    Ginos JZ; Cotzias GC; Tolosa E; Tang LC; LoMonte A
    J Med Chem; 1975 Dec; 18(12):1194-1200. PubMed ID: 1238569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine.
    Kamata K; Okuyama S; Hashimoto S; Aihara H; Kasuya Y
    Jpn J Pharmacol; 1986 Oct; 42(2):329-32. PubMed ID: 3795627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.
    Feigenbaum JJ; Moon BH; Catterton R; Yanai J; Klawans HL
    Psychopharmacology (Berl); 1982; 78(4):383-4. PubMed ID: 6818604
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat.
    Schoenfeld RI; Neumeyer JL; Dafeldecker W; Roffler-Tarlov S
    Eur J Pharmacol; 1975 Jan; 30(1):63-8. PubMed ID: 1168137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ; Pinder RM
    J Pharm Pharmacol; 1974 Oct; 26(10):753-6. PubMed ID: 4156532
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
    Koller WC; Weiner WJ; Diamond BI; Nausieda PA; Klawans HL
    Neuropharmacology; 1980 Sep; 19(9):831-7. PubMed ID: 7191490
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine.
    Friedman E; Rotrosen J; Gurland M; Lambert GA; Gershon S
    Life Sci; 1975 Sep; 17(6):867-73. PubMed ID: 1238887
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is morphine-induced catalepsy related to activation of dopaminergic neurones?
    Moleman P; Versluis DJ; Bruinvels J
    Psychopharmacology (Berl); 1978 Dec; 60(1):35-9. PubMed ID: 104343
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothermic effects of apomorphine homologues in mice.
    Menon MK; Clark WG; Cannon JG
    J Pharm Pharmacol; 1979 May; 31(5):318-21. PubMed ID: 37302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour.
    Cools AR
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):259-69. PubMed ID: 5126063
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K; Yamamura M
    Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic effects of lergotrile: possible involvement of a metabolite.
    McDevitt JT; Setler PE
    Neuropharmacology; 1980 Jun; 19(6):537-42. PubMed ID: 6105627
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK; Clark WG; Neumeyer JL
    Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.